Top Markets
#1 DeFiChain DeFiChain +2,516.54%
#2 Akedo Akedo +207.46%
#3 ONFA ONFA +54.25%
#4 Metaplex Metaplex +23.40%
#5 Osaka Protocol Osaka Protocol +21.73%
#6 Talus Network Talus Network +20.44%
#7 Wrapped Krown Wrapped Krown +20.00%
#8 eCash eCash +19.86%
#9 DODO DODO +17.78%
#10 Black Phoenix Black Phoenix +15.04%
Coin of the day
DeFiChain DeFiChain
Inställningar
Språk
SVENSKA
Valuta
USD
Tema
Valbiotis SA Valbiotis SA

Valbiotis SA

ALVAL
Rankning i aktier #16315
Valbiotis SA engages in the research and development of health nutrition... Valbiotis SA engages in the research and development of health nutrition products to prevent and combat metabolic and cardiovascular diseases. The company develops TOTUM-63 that is in Phase II/III clinical trials for the treatment of type 2 diabetes; TOTUM-070, which is in Phase II clinical trials to treat hypercholesterolemia; and TOTUM-854 that is in Phase II/III clinical trials for arterial hypertension. It also develops TOTUM-448 for the treatment of patient with non-alcoholic fatty liver disease. It has a strategic partnership with Nestlé Health Science. Valbiotis SA was incorporated in 2014 and is headquartered in Périgny, France.
Aktiekurs
$0.94180721
Marknadsvärde
$22.26M
Förändring (1 dag)
0.38%
Förändring (1 år)
-14.35%
Land
FR
Handel Valbiotis SA (ALVAL)

Kategori

Healthcare
P/B-tal för Valbiotis SA (ALVAL)
P/B-tal per July 2026 TTM: 2.69
Enligt Valbiotis SA senaste finansiella rapporter och aktiekurs är det aktuella P/B-talet (TTM) 2.69. I slutet av 2023 hade företaget ett P/B-tal på 3.18.
Historik för P/B-tal för Valbiotis SA från 2015 till 2026
P/B-tal vid årets slut
År P/B-tal Ändra
2026 (TTM) 2.69 16.05%
2024 2.32 -27.16%
2023 3.18 16.23%
2022 2.74 -37.95%
2021 4.41 -30.21%
2020 6.32 392.65%
2019 1.28 -22.00%
2018 1.64 -0.78%
2017 1.66 -98.28%
2016 96.41 6,215.43%
2015 1.53 0.00%
P/B-tal för liknande företag eller konkurrenter
Företag P/B-tal Skillnad i P/B-tal Land
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 6.9942 159.78%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.251 132.17%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 2.1715 -19.35%
US
UCB SA UCB SA
UCB SA
UCB.BR
 4.065 50.98%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 7.3009 171.17%
NL